Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks.
Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks.
<iframe src="https://hindustansphere.com/embed/cluster/7e672160627b4436a9950e8ca45436397fa5fb69" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%"></iframe>
